Abstract
Background: Gliomas represent the most frequent primary tumors of central nervous system (CNS), contributing to more than half of the incidence of brain tumors. Cancer stem cell markers (CSC) identify a group of patients at high risk for progression. Nestin is an intermediate fi lament (IF) protein was first described as a neural stem cell/progenitor cell marker.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have